Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amodiaquine (camoquin) (1 trial)
dihydroqinghaosu (1 trial)
folic acid (1 trial)
menafrivac (1 trial)
piperaquinoline (1 trial)
pyrimethamine (daraprim) (3 trials)
sulfadoxine (3 trials)
gsk 2189242a (1 trial)
live oral poliovirus type 1, 2 and 3 (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
stamaril (1 trial)
synflorix (1 trial)
tritanrix-hepb (1 trial)
tenofovir (viread) (1 trial)
vitamin a (1 trial)
Anemia (Phase 3)
Malaria (Phase 3)
Meningitis (Phase 3)
Streptococcal Infections (Phase 2)
Trials (8 total)
Trial APIs (15 total)